Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parainfluenza virus 5 (PIV5), formerly known as simian virus 5 (SV5), is a negative-sense, nonsegmented, single-stranded RNA virus belonging to the family *Paramyxoviridae*. It is closely related to other paramyxoviruses such as mumps virus and human parainfluenza viruses types 2 and 4. PIV5 has been widely used as a viral vector in vaccine development for both human and veterinary applications due to its favorable safety profile, genomic stability, and ability to accommodate foreign genes.
The PIV5 vector delivers genetic material (antigens) into host cells, leading to antigen presentation and subsequent activation of the immune system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parainfluenza Virus 5 Vector (PIV5 Vector).